E. Oravcová

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome

V. Krčméry, E. Oravcová, S. Špánik et al. · Journal of Antimicrobial Chemotherapy · 1998 · 101 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer

Javier Cortés, Véronique Dièras, Sylvie Lorenzen et al. · JAMA Oncology · 2020 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Viridans Streptococcal Bacteraemia Due to Penicillin-Resistant and Penicillin-Sensitive Streptococci: Analysis of Risk Factors and Outcome in 60 Patients from a Single Cancer Centre Before and After Penicillin is Used for Prophylaxis

S. Špánik, J. Trupl, A. Kunová et al. · Scandinavian Journal of Infectious Diseases · 1997 · 42 citations

Veterinary Medicine, Infectious Diseases, Microbiology +16

Candidaglabrata, Candidakrusei, Non-albicans Candida spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of Fluconazole

A. Kunová, J. Trupl, S. Špánik et al. · Chemotherapy · 2009 · 28 citations

Medicine, Microbiology, Oncology +13

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.

Michal Mego, L. Ebringer, Ľuboš Drgoňa et al. · PubMed · 2005 · 28 citations

Medicine, Oncology, Pharmacology +13